BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2013

Jun 5, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2013-06-03

Reporting Person: FUCHS HENRY J (EVP, Chief Medical Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-06-03	Common Stock	S	1098	$58.3205	Disposed	43266	Direct

Footnotes

F1: Transaction made pursuant to 10b5-1 trading plan executed on May 8, 2013

F2: The price in column 4 is weighted average price. The price actually received ranged from $57.58 to $61.42. The reporting person will provide to the isuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.